We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
ZeptoMetrix an Antylia scientific company

Download Mobile App




Gastrin Levels Linked to Helicobacter-Induced Stomach Cancer

By LabMedica International staff writers
Posted on 01 Jul 2009
Researchers working with mouse models have found that the stomach hormone gastrin is critically linked to the form of stomach cancer that may results from infection by Helicobacter bacteria.

Stomach cancer, which is the second leading cause of cancer-related deaths worldwide, has been strongly linked to Helicobacter infection. More...
These bacteria, which cause chronic inflammation of the stomach lining, infect nearly half of the world's population and have been shown to cause the development of gastric ulcers and stomach cancer.

In the current study, investigators from Columbia University Medical Center (New York, NY, USA) examined the influence of the stomach hormone gastrin, which is elevated by Helicobacter infection, on the development of stomach cancer. They worked with several mouse lines including gastrin-deficient (GAS-KO) mice and C57BL/6 wild-type mice. The animals were infected with H. felis for either 12 or 18 months and then examined for the presence of stomach cancer.

Results published in the July 2009 issue of The American Journal of Pathology revealed that neither too little nor too much gastrin was a healthy situation. Elevated levels of gastrin initiated development of tumors in the gastric corpus (main body of the stomach), but absence of gastrin also induced tumors in the gastric antrum, the lower section of the stomach that empties into the small intestine.

The bimodal effect of gastrin may be linked to the hormone's role in protecting the stomach mucosa from damage caused by gastric acid secretion induced by gastrin itself. Thus, either too much or too little gastrin could predispose a person to stomach cancer.

"Clinicians in the future may need to be more careful about prescribing acid-suppressive drugs for long-term use in patients infected with Helicobacter,” said senior author Dr. Timothy Wang, professor of Medicine at Columbia University Medical Center.

Related Links:

Columbia University Medical Center




Platinum Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay
Verification Panels for Assay Development & QC
Seroconversion Panels
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
Melanoma Panel
UltraSEEK Melanoma Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.